The Anxiety scale (ANX) represents one of the three core subscales of the Depression Anxiety Stress Scales (DASS)<\/a>, developed by Peter F. Lovibond and Sydney H. Lovibond in 1995 at the University of New South Wales. Designed to address the long-standing psychometric challenge of diagnostic overlap and symptom conflation between affective and anxiety disorders, the ANX subscale specifically isolates the unique dimension of autonomic arousal<\/a>, skeletal muscle reactivity, situational apprehension, and the subjective experience of anxious affect. The full version comprises 14 items (with a psychometrically equivalent 7-item short form in the DASS-21), scored on a 4-point Likert-type scale<\/a> ranging from 0 (“Did not apply to me at all”) to 3 (“Applied to me very much, or most of the time”), evaluating symptom frequency and severity over the past week.<\/p>\n Extensive psychometric investigations confirm that the ANX scale demonstrates outstanding internal consistency, with Cronbach\u2019s alpha<\/a> typically ranging between .84 and .92 in non-clinical cohorts and exceeding .90 in clinical populations. Confirmatory factor analyses repeatedly validate its empirical distinctiveness from the Depression (DEP) and Stress (STR) subscales, demonstrating superior discriminant validity when compared to classic legacy instruments such as the Beck Anxiety Inventory (BAI)<\/a> and the State-Trait Anxiety Inventory (STAI). The scale strongly aligns with the physiological hyperarousal component of Clark and Watson\u2019s Tripartite Model of Anxiety and Depression<\/a>. Widely translated into over 50 languages and normalized across diverse international demographics, the DASS-ANX subscale serves as a foundational instrument for psychiatric epidemiology, clinical psychology assessment, neuropsychological research, and longitudinal treatment-monitoring programs worldwide.<\/p>\n Anxiety Scale, DASS-ANX, Depression Anxiety Stress Scales, Autonomic Arousal, Psychometrics, Physiological Hyperarousal, Tripartite Model, Construct Validity, Confirmatory Factor Analysis, Internal Consistency, Clinical Assessment, Neuroticism<\/p>\n The Anxiety scale (ANX) of the Depression Anxiety Stress Scales was developed by:<\/p>\n Official correspondence regarding the instrument, normative tables, and permissions has historically been administered via the School of Psychology at the University of New South Wales and the Psychology Foundation of Australia.<\/p>\n The primary purpose of the Anxiety (ANX) scale is to provide a pure, dimensionally focused psychometric index of anxiety that is empirically separated from depressive mood<\/a> and generalized tension or stress. Historically, self-report inventories measuring emotional distress\u2014such as early iterations of the Beck Depression Inventory (BDI), the Minnesota Multiphasic Personality Inventory (MMPI) mood scales, and the Taylor Manifest Anxiety Scale\u2014suffered from extensive construct contamination. Most self-report anxiety scales correlated so heavily with depression inventories (often r<\/em> = .60 to .80) that clinicians and clinical researchers were unable to determine whether an intervention specifically alleviated anxiety, ameliorated dysphoric mood, or merely reduced an undifferentiated general factor of psychological distress or neuroticism<\/a><\/span>.<\/p>\n The Lovibonds initiated a long-term research program aimed at mapping the precise empirical boundaries of non-specific negative affectivity versus the specific core symptoms unique to anxiety and depression. Through iterative empirical item analysis with non-clinical university students and clinical patient cohorts, they discovered that anxiety, in its purest differentiating manifestation, is defined by physiological hyperarousal, autonomic hyperactivity (e.g., tachycardia, diaphoresis, dyspnea, dry mouth), skeletal musculature trembling, and immediate situational panic-like terror. The purpose of the ANX scale is therefore twofold:<\/p>\n The construct assessed by the Anxiety (ANX) scale is multi-faceted yet strictly delimited, operationalizing anxiety as an acute emotional response marked by autonomic activation, subjective apprehension, and physical somatic sensations. Rather than measuring a heterogeneous composite of diffuse worries, everyday life hassles, or existential demoralization, the ANX scale measures four explicit sub-dimensions of the anxiety construct:<\/p>\n The predominant core of the ANX subscale reflects the peripheral physiological manifestations of the sympathetic nervous system’s “fight-or-flight” cascade. This includes items assessing cardiovascular hyperreactivity (e.g., conscious awareness of heart pounding, palpitations, or tachycardia in the absence of physical exertion), respiratory distress (e.g., shortness of breath, hyperventilation, difficulty catching one’s breath without physical cause), and secretory or thermal dysregulation (e.g., dryness of the mouth, sudden perspiration, cold or clammy extremities). For instance, a patient experiencing autonomic surge during an uncued panic episode rapidly endorses severe manifestations on these somatic markers.<\/p>\n A second central dimension focuses on overt musculoskeletal reactions induced by neuroendocrine discharge (e.g., epinephrine and norepinephrine signaling). This includes involuntary tremors, shaking hands, postural instability, and physical shakiness. Unlike generalized muscle tightness (which characterizes the DASS Stress subscale and generalized anxiety disorder criteria), the skeletal items of the ANX subscale capture visible, destabilizing somatic tremor that interferes with motor stability and signals immediate neurovegetative arousal.<\/p>\n The ANX scale captures the anticipatory dread and situational panic that emerges when an individual encounters or anticipates situations that could precipitate acute fear or social embarrassment. It measures the anticipatory sense that panic or incapacitation is imminent (e.g., fear of panicking and making a fool of oneself in public or interpersonal contexts). This symptom connects the subjective cognitive fear of loss of physical or behavioral control directly to interoceptive cues.<\/p>\n Finally, the scale measures subjective terror, panic-like apprehension, faintness, and dread that occur independently of objective external threats. This includes descriptions of experiencing acute episodes of unprovoked fear, feeling “scared for no good reason,” feeling close to panic, or sensing bodily disequilibrium (such as dizziness, faintness, or feeling on the verge of physical collapse). Together, these facets capture the physiological, subjective, and interoceptive constellation that clinical psychopathology terms acute somatic anxiety.<\/p>\n The theoretical architecture underpinning the Anxiety (ANX) scale is grounded in the intersection of cognitive-behavioral theory, neurobiological paradigms of fear conditioning, and quantitative dimensional models of psychopathology. Most notably, the development of the scale was directly informed by, and serves as one of the primary empirical pillars for, the Tripartite Model of Anxiety and Depression<\/a> formulated by Lee Anna Clark and David Watson (1991).<\/p>\n Clark and Watson proposed that the pervasive diagnostic comorbidity and high psychometric correlation between depressive and anxious syndromes could be mathematically explained by decomposing internalizing psychopathology into three distinct dimensions:<\/p>\n Lovibond and Lovibond\u2019s empirical findings (1995) verified that most established anxiety instruments\u2014such as the Beck Anxiety Inventory (BAI) and the State-Trait Anxiety Inventory (STAI)\u2014were saturated either with general negative affect or with heterogeneous mixtures of worry and dysphoria. The DASS ANX subscale was engineered to be the purest self-report operationalization of the Physiological Hyperarousal (PH)<\/strong> dimension. While the DASS Depression (DEP) subscale maps onto Low Positive Affect \/ Anhedonia, and the DASS Stress (STR) subscale maps onto chronic tension and high Negative Affectivity, the ANX subscale specifically targets autonomic nervous system dysregulation.<\/p>\n From a neurobiological standpoint, the ANX scale reflects threshold sensitivities within the hypothalamic-pituitary-adrenal (HPA) axis<\/a> and the central amygdalar fear circuitry. When an individual exhibits elevated ANX scores, it indexes a hyper-sensitized neurovisceral loop: amygdala efferents stimulate the locus coeruleus and paraventricular nucleus, generating rapid somatic feedback (tachycardia, tachypnea, peripheral vasoconstriction) that is catastrophically misinterpreted via interoceptive cognitive appraisal mechanisms (as conceptualized in David M. Clark\u2019s cognitive model of panic). Thus, the Lovibond ANX scale encapsulates both the primitive somatic output of fear neurocircuitry and the subjective dread that accompanies acute interoceptive surges.<\/p>\n The construct, convergent, discriminant, and criterion-related validity of the Anxiety (ANX) scale has been substantiated through hundreds of independent empirical investigations worldwide across non-clinical, student, psychiatric outpatient, and community populations.<\/p>\n The ANX subscale demonstrates high, statistically significant convergent correlations with established legacy measures of anxiety:<\/p>\n The primary psychometric triumph of the DASS ANX scale lies in its exceptional discriminant validity:<\/p>\n Criterion validity is evidenced by the scale’s capacity to differentiate between distinct psychiatric diagnostic categories established by structured clinical interviews (such as the SCID). Patients meeting DSM-IV and DSM-5 diagnostic criteria for Panic Disorder, Agoraphobia, and Specific Phobias score significantly higher on the DASS-ANX subscale than patients diagnosed with Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD), whose scores are instead characterized by elevations on the DEP and STR scales, respectively (Brown et al., 1997). In longitudinal clinical trials, reductions in ANX scores systematically predict reductions in autonomic panic frequency during cognitive-behavioral exposure therapies.<\/p>\n The reliability of the Anxiety (ANX) scale has been documented across dozens of psychometric investigations, proving exceptionally robust across varied demographic, cultural, and linguistic cohorts.<\/p>\n Internal consistency estimates using Cronbach’s alpha<\/a> ($\u0007lpha$<\/span>) and McDonald’s omega<\/a> ($\\omega$<\/span>) consistently fall well above the recommended academic threshold of .80 for basic research and .90 for clinical decision-making:<\/p>\n Because the DASS ANX scale evaluates symptom state severity over the preceding week (“over the past week”), test-retest reliability reflects both temporal stability of the latent tendency and legitimate responsiveness to situational change:<\/p>\n The Standard Error of Measurement (SEM) for the 14-item ANX scale is generally small (SEM \u2248 1.8 to 2.3 score points on the 0\u201342 raw metric), indicating high precision around individual observed scores. This low measurement error provides clinicians with tight confidence intervals<\/span> (typically $\\pm 4$<\/span> points at the 95% level) when evaluating whether an individual’s score crosses clinical cutoffs.<\/p>\n The structural dimensionality of the DASS, and specifically the Anxiety (ANX) scale, has been one of the most rigorously debated and replicated areas in modern psychometric literature.<\/p>\n In the original scale construction phases, Lovibond and Lovibond (1995) subjected large item pools representing affective distress to principal components analysis<\/a> and maximum-likelihood exploratory factor analyses with oblique (oblimin) rotation. The items specifically written to capture autonomic arousal, trembling, situational panic, and interoceptive dread cleanly loaded onto a discrete factor (eigenvalues substantially greater than 1.0), with primary item factor loadings typically exceeding .50, while cross-loadings on the Depression and Stress factors were virtually all below .25. This clean separation formed the 14 items comprising the final ANX scale.<\/p>\n Extensive CFA studies have consistently tested competitive models to determine whether negative affect is better represented as a unidimensional construct, a two-factor construct (anxiety vs. depression), a three-factor correlated model, or a quadripartite bifactor model:<\/p>\n The Anxiety (ANX) scale can be administered as an independent stand-alone scale or as part of the complete Depression Anxiety Stress Scales (either the full 42-item instrument or the 21-item short form). Below is the comprehensive technical profile of the measurement tool:<\/p>\n The Depression Anxiety Stress Scales, including the Anxiety (ANX) subscale, were officially published in 1995<\/strong> by Peter F. Lovibond and Sydney H. Lovibond following nearly a decade of psychometric piloting and scale refinement.<\/p>\n Below is a curated selection of foundational literature and psychometric validation studies on the Anxiety (ANX) scale formatted in APA 7th edition:<\/p>\n Instructions to Respondents:<\/strong> Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement applied to you over the past week. There are no right or wrong answers. Do not spend too much time on any one statement.<\/p>\n Rating Scale:<\/strong><\/p>\n The 14 Items of the DASS Anxiety (ANX) Subscale:<\/strong><\/p>\n2. Keywords<\/h2>\n
3. Authors<\/h2>\n
\n
4. Purpose<\/h2>\n
\n
5. Psychological Construct<\/h2>\n
Autonomic Arousal and Sympathetic Activation<\/h3>\n
Skeletal Musculature and Motor Tension Effects<\/h3>\n
Situational and Phobic Apprehension<\/h3>\n
Subjective Felt Experience of Anxious Affect<\/h3>\n
6. Theoretical Framework<\/h2>\n
The Tripartite Model Integration<\/h3>\n
\n
Neurobiological and Cognitive Dimensions<\/h3>\n
7. Validity<\/h2>\n
Convergent Validity<\/h3>\n
\n
Discriminant Validity<\/h3>\n
\n
Criterion and Predictive Validity<\/h3>\n
8. Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Stability<\/h3>\n
\n
Standard Error of Measurement<\/h3>\n
9. Factor Analysis<\/h2>\n
Exploratory Factor Analysis (EFA)<\/h3>\n
Confirmatory Factor Analysis (CFA)<\/h3>\n
\n
10. Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
\n
0<\/code> = Did not apply to me at all (Never)<\/li>\n1<\/code> = Applied to me to some degree, or some of the time (Sometimes)<\/li>\n2<\/code> = Applied to me to a considerable degree, or a good part of time (Often)<\/li>\n3<\/code> = Applied to me very much, or most of the time (Almost Always)<\/li>\n<\/ul>\n<\/li>\n\n
0 to 42<\/code>.<\/li>\n\n
0 \u2013 7<\/code> (Percentile: 0 \u2013 78%)<\/li>\n8 \u2013 9<\/code> (Percentile: 79 \u2013 86%)<\/li>\n10 \u2013 14<\/code> (Percentile: 87 \u2013 94%)<\/li>\n15 \u2013 19<\/code> (Percentile: 95 \u2013 97%)<\/li>\n20+<\/code> (Percentile: 98 \u2013 100%)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n11. Permissions & Fee and Test Year<\/h2>\n
\n
12. References<\/h2>\n
\n
13. Items of the Scale<\/h2>\n
\n
\n\n